04.09.2019 Issue 446

   
Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Round-up
The Top Story in HEOR: Latest Headlines in HEOR:

Peeples, HealthCore-NERI's Siami Spotlight Changing
Clinical Trial Paradigm for Rare, Orphan Diseases

Tuesday, April 9

Dr. Patti Peeples, HealthEconomics.Com founder and CEO, recently discussed with HealthCore-NERI's Flora Siami on the evolving clinical trial landscape for orphan and rare diseases using real-world evidence.

Survey Finds Big Push to Bolster Data Analytics Strategies

Report: Competition High for Data Scientists

MAPS Announces New Guidance Resource

Policymakers Move on Drug Pricing Bill

AMCP Seeks Comments on Framework

ICER Recommends Major Price Drop for Spinraza

Survey: Americans Borrowed $88 Billion for Health Costs in 2018


US Market Access Engagement Manager/ Director

Senior Medical Writer

Senior Research Analyst (HEOR)

Scientific Writer

Industry Spotlight


Conferences Webinars
3rd Annual Innovative Pharma Pricing & Market Access Strategies Summit
    April 10-11, Berlin, Germany

16th Annual Pharmaceutical Compliance Congress
    April 16-18, Washington, D.C.

Economic Evaluation for Oncology
    April 23, York, England

Future of OCM and Advanced Payment Models in Oncology
    April 25, Chicago, Illinois

Big Data, RWD and RWE: What’s the Difference and How is it Changing the Research Landscape?
    April 15

New Drug Pricing Strategies for a Changing Global Market
    April 24

Beyond Drug Development: The Increasing Role of Real-World Data and Real-World Evidence in Medical Research
    April 25


Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
Review of Influence: The Institute for Clinical and Economic Review

Innovative Drugs: Mapping the Pricing and Reimbursement Landscape

Orphan Drugs: European Payer Perspectives

Do Payers Really Want Pay-for-Performance?

Payer Engagement: Benchmarking Team Structure and Activity

Benchmarking Market Access Strategies for High-Cost Drugs, Biologics

Blockchain: Transformational Change for Pharma?

2018 Specialty Drug Trends

The Global Use of Medicine in 2019 and Outlook to 2023

Breaking Through the Hype of Real-World Evidence

Time to Market: Accelerating Market Access

Orphan Drugs in the United States

Charting Real World Data and Evidence – Activity and Capabilities (2018)


 
Special Thanks to Our Partners:
             Truven    
              Evidera    HealthCore    University of FL
Xcenda    OM1    Parexel    Jefferson     Dymaxium
Precision Xtract    Pharmerit    eMax Health    Sciformix
Evidence Partners     ICON
Share this newsletter on social media:

Email Twitter Facebook LinkedIn